Follicum

Kancera
Follicum is developing a new pharmaceutical treatment for controlling hair growth. The first clinical studies in humans are planned to begin turn of the year 2015/2016, and intended to confirm the positive preclinical results of candidate drug FOL-005.

 Kancera focuses on pharmaceutical development of drug candidates based on new treatment. At present Kancera is primarily developing drugs for the treatment of leukemia and solid tumors.



 Agrisera blog

Agrisera blog

Archive


Close